ARCHIVES

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Magnuson In Line For Appropriations Chairmanship

December 2, 1977

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011